Practice Tips and Tools for the Successful Use of U-500 Regular Human Insulin
- 24 October 2013
- journal article
- research article
- Published by SAGE Publications in The Diabetes Educator
- Vol. 40 (2) , 153-165
Abstract
This review provides information to equip diabetes educators to instruct and guide patients in using U-500 human regular insulin (U-500R). The article includes an overview of U-500R pharmacology and clinical data, strategies for outpatient and inpatient use, and tools for patient education. U-500R is useful for treating patients with any type of diabetes who require high doses of insulin. U-500R alleviates the volume-related problems associated with high doses of U-100 insulin, making treatment with high doses of insulin more feasible (because of the need for fewer injections for patients) as well as more cost-efficient and potentially more effective. These tools can help diabetes educators feel more comfortable and confident as they advise and educate patients who receive high-dose U-500R as part of their overall diabetes care plan. The diabetes educator plays a vital role in helping patients use U-500R safely and successfully.Keywords
This publication has 42 references indexed in Scilit:
- Changes to medication-use processes after overdose of U-500 regular insulinAmerican Journal of Health-System Pharmacy, 2012
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese SubjectsDiabetes Care, 2011
- Randomized Trial on the Influence of the Length of Two Insulin Pen Needles on Glycemic Control and Patient Preference in Obese Patients with DiabetesDiabetes Technology & Therapeutics, 2011
- Addressing safety concerns about U-500 insulin in a hospital settingAmerican Journal of Health-System Pharmacy, 2011
- Use of concentrated insulin human regular (U-500) for patients with diabetesAmerican Journal of Health-System Pharmacy, 2010
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Ongoing Incidents Involving Fentanyl Patches are Alarming!; Insulin CONCENTRATE U-500; WHO: Dilute Vincristine in a MinibagHospital Pharmacy, 2007
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Insulin Resistance and the Use of U-500 Insulin: A Case ReportThe Diabetes Educator, 1987